Abstract:Rationale: Dysbiosis of gut microbiota plays an important role in cardiovascular diseases but the molecular mechanisms are complex. An association between gut microbiome and the variance in HDL-C (high-density lipoprotein-cholesterol) level was suggested in a human study. Besides, dietary fat was shown to increase both HDL-C and LDL-C (low-density lipoprotein-cholesterol) levels. We speculate that certain types of gut bacteria responding to dietary fat may help to regulate HDL-C level and potentially affect atherosclerotic development. Objective: We aimed to investigate whether and how high-fat diet (HFD)-associated gut microbiota regulated HDL-C level. Methods and Results: We found that HFD increased gut flagellated bacteria population in mice. The increase in HDL-C level was adopted by mice receiving fecal microbiome transplantation from HFD-fed mouse donors. HFD led to increased hepatic but not circulating flagellin, and deletion of TLR5 (Toll-like receptor 5), a receptor sensing flagellin, suppressed HFD-stimulated HDL-C and ApoA1 (apolipoprotein A1) levels. Overexpression of TLR5 in the liver of TLR5-knockout mice was able to partially restore the production of ApoA1 and HDL-C levels. Mechanistically, TLR5 activation by flagellin in primary hepatocytes stimulated ApoA1 production through the transcriptional activation responding to the binding of NF-κB (nuclear factor-κB) on Apoa1 promoter region. Furthermore, oral supplementation of flagellin was able to stimulate hepatic ApoA1 production and HDL-C level and decrease atherosclerotic lesion size in apolipoprotein E-deficient ( Apoe −/− ) mice without triggering hepatic and systemic inflammation. The stimulation of ApoA1 production was also seen in human ApoA1-transgenic mice treated with oral flagellin. Conclusions: Our finding suggests that commensal flagellated bacteria in gut can facilitate ApoA1 and HDL-C productions in liver through activation of TLR5 in hepatocytes. Hepatic TLR5 may be a potential drug target to increase ApoA1.

Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin

CCAAT/enhancer-binding Protein Δ is a Critical Mediator of Lipopolysaccharide-Induced Acute Lung Injury.

Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response.

CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice

CREBH regulation of lipid metabolism through multifaceted functions that improve arteriosclerosis

Gut Microbiota-Associated Activation of TLR5 Induces Apolipoprotein A1 Production in the Liver

The Role and Mechanism of CREBH Regulating SIRT3 in Metabolic Associated Fatty Liver Disease

TLR4/MyD88 -mediated CCL2 production by lipopolysaccharide (endotoxin): Implications for metabolic inflammation

Involvement of Up-Regulated CXC Chemokine Ligand 16/scavenger Receptor That Binds Phosphatidylserine and Oxidized Lipoprotein in Endotoxin-Induced Lethal Liver Injury Via Regulation of T-cell Recruitment and Adhesion.

Low-Dose Endotoxin Induces Inflammation by Selectively Removing Nuclear Receptors and Activating CCAAT/Enhancer-Binding Protein δ

Adenylyl Cyclase 6 Activation Negatively Regulates TLR4 Signaling Through Lipid Raft–Mediated Endocytosis

TLR4 (Toll-Like Receptor 4)-Dependent Signaling Drives Extracellular Catabolism of LDL (Low-Density Lipoprotein) Aggregates

Bacterial Endotoxin Stimulates Adipose Lipolysis Via Toll-Like Receptor 4 and Extracellular Signal-regulated Kinase Pathway

Adenylyl cyclase 6 activation negatively regulates TLR4 signaling through lipid raft-mediated endocytosis (P4169)

TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells

Regulation by Ddah/Adma Pathway of Lipopolysaccharide-Induced Tissue Factor Expression in Endothelial Cells

PCTR1 ameliorates lipopolysaccharide-induced acute inflammation and multiple organ damage via regulation of linoleic acid metabolism by promoting FADS1/FASDS2/ELOV2 expression and reducing PLA2 expression

TLR4 Mediates LPS-induced HO-1 Expression in Mouse Liver: Role of TNF-α and IL-1β

Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells

LPS exposure alleviates multiple tissues damage by facilitating macrophage efferocytosis

β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H